Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Medical management of rheumatoid arthritis.

× No keyword cloud information.

28 in total

Review 1. Misoprostol for the treatment of peptic ulcer and antiinflammatory-drug-induced gastroduodenal ulceration.

Authors: R P Walt
Journal: N Engl J Med Date: 1992-11-26 Impact factor: 91.245

Review 2. Slow drugs: slow progress? Use of slow acting antirheumatic drugs (SAARDs) in rheumatoid arthritis.

Authors: H A Capell; M Brzeski
Journal: Ann Rheum Dis Date: 1992-03 Impact factor: 19.103

3. CAMPATH-1H in inflammatory arthritis.

Authors: R A Watts; J D Isaacs; G Hale; B L Hazleman; H Waldmann
Journal: Clin Exp Rheumatol Date: 1993 Mar-Apr Impact factor: 4.473

4. Gold salts in the treatment of rheumatoid arthritis. A double-blind study.

Authors: J W Sigler; G B Bluhm; H Duncan; J T Sharp; D C Ensign; W R McCrum
Journal: Ann Intern Med Date: 1974-01 Impact factor: 25.391

5. Combination therapy in rheumatoid arthritis--no benefit of addition of hydroxychloroquine to patients with a suboptimal response to intramuscular gold therapy.

Authors: D R Porter; H A Capell; J Hunter
Journal: J Rheumatol Date: 1993-04 Impact factor: 4.666

6. Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis.

Authors: D Porter; R Madhok; J A Hunter; H A Capell
Journal: Ann Rheum Dis Date: 1992-04 Impact factor: 19.103

7. Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial.

Authors: H J Williams; J R Ward; J C Reading; R H Brooks; D O Clegg; J L Skosey; M H Weisman; R F Willkens; J Z Singer; G S Alarcón
Journal: Arthritis Rheum Date: 1992-03

8. Bone mineral density of the hip and of the anteroposterior and lateral dimensions of the spine in men with rheumatoid arthritis. Effects of low-dose corticosteroids.

Authors: M J Garton; D M Reid
Journal: Arthritis Rheum Date: 1993-02

Medical management of rheumatoid arthritis.

Review 1. Misoprostol for the treatment of peptic ulcer and antiinflammatory-drug-induced gastroduodenal ulceration.

Review 2. Slow drugs: slow progress? Use of slow acting antirheumatic drugs (SAARDs) in rheumatoid arthritis.

3. CAMPATH-1H in inflammatory arthritis.

4. Gold salts in the treatment of rheumatoid arthritis. A double-blind study.

5. Combination therapy in rheumatoid arthritis--no benefit of addition of hydroxychloroquine to patients with a suboptimal response to intramuscular gold therapy.

6. Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis.

7. Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial.

8. Bone mineral density of the hip and of the anteroposterior and lateral dimensions of the spine in men with rheumatoid arthritis. Effects of low-dose corticosteroids.

9. The relative toxicity of disease-modifying antirheumatic drugs.

10. Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update.

Review 1. Tolerability of topical NSAIDs in the elderly: do they really convey a safety advantage?

2. Medical management of rheumatoid arthritis.

3. Relationship between sonographic parameters and YKL-40 levels in rheumatoid arthritis.